Accretive Health and Ascension Announce Long-Term Strategic Partnership
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Cowen Upgrades Accretive Health (ACHI) to Outperform
December 9, 2015 7:16 AM ESTCowen upgraded Accretive Health (OTCBB: ACHI) from Neutral to Outperform with a price target of $5.00.
Analyst Charles Rhyee commented, "We upgrade shares of ACHI to Outperform from Market Perform following the announcement it has renewed and expanded its existing MSA with Ascension.... More
